These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

779 related articles for article (PubMed ID: 19114099)

  • 21. Enhanced efficacy of triprolidine by transdermal application of the EVA matrix system in rabbits and rats.
    Shin SC; Choi JS
    Eur J Pharm Biopharm; 2005 Sep; 61(1-2):14-9. PubMed ID: 16005195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silicone adhesive, a better matrix for tolterodine patches-a research based on in vitro/in vivo studies.
    Liu J; Wang Z; Liu C; Xi H; Li C; Chen Y; Sun L; Mu L; Fang L
    Drug Dev Ind Pharm; 2012 Aug; 38(8):1008-14. PubMed ID: 22126709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane.
    Suedee R; Bodhibukkana C; Tangthong N; Amnuaikit C; Kaewnopparat S; Srichana T
    J Control Release; 2008 Aug; 129(3):170-8. PubMed ID: 18550193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel biomaterial for transdermal application: in vitro and in vivo characterization.
    Mundada AS; Avari JG
    Drug Deliv; 2011 Aug; 18(6):424-31. PubMed ID: 21554152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo evaluation of limonene-based transdermal therapeutic system of nicorandil in healthy human volunteers.
    Krishnaiah YS; Chandrasekhar DV; Rama B; Jayaram B; Satyanarayana V; Al-Saidan SM
    Skin Pharmacol Physiol; 2005; 18(6):263-72. PubMed ID: 16113596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ketorolac tromethamine transdermal gel: development, in vitro and in vivo evaluation.
    Dubey R; Bommagani M; Venkateswarlu V; Mullangi R; Karnati HR; Thammera RK; Menon VC
    J Pain Palliat Care Pharmacother; 2009; 23(1):26-34. PubMed ID: 19296352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proniosomal transdermal therapeutic system of losartan potassium: development and pharmacokinetic evaluation.
    Thakur R; Anwer MK; Shams MS; Ali A; Khar RK; Shakeel F; Taha EI
    J Drug Target; 2009 Jul; 17(6):442-9. PubMed ID: 19527115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of transdermal therapeutic formulation of CNS5161, a novel NMDA receptor antagonist, by utilizing pressure-sensitive adhesives II: improved transdermal absorption and evaluation of efficacy and safety.
    Naruse M; Ogawara K; Kimura T; Konishi R; Higaki K
    Eur J Pharm Sci; 2014 Feb; 52():86-94. PubMed ID: 24215737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a Prolonged-Release Pramipexole Transdermal Patch: In Vitro and In Vivo Evaluation.
    Pu T; Li X; Sun Y; Ding X; Pan Y; Wang Q
    AAPS PharmSciTech; 2017 Apr; 18(3):738-748. PubMed ID: 27245330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formulation and Pharmacokinetic Evaluation of a Drug-in-Adhesive Patch for Transdermal Delivery of Koumine.
    Su Y; Lu W; Fu X; Xu Y; Ye L; Yang J; Huang H; Yu C
    AAPS PharmSciTech; 2020 Oct; 21(8):297. PubMed ID: 33099696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo evaluation of the transdermal iontophoretic delivery of sumatriptan succinate.
    Patel SR; Zhong H; Sharma A; Kalia YN
    Eur J Pharm Biopharm; 2007 May; 66(2):296-301. PubMed ID: 17182233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of O-acylmenthol on transdermal delivery of drugs with different lipophilicity.
    Zhao L; Fang L; Xu Y; Zhao Y; He Z
    Int J Pharm; 2008 Mar; 352(1-2):92-103. PubMed ID: 18053661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transdermal delivery of tolterodine by O-acylmenthol: In vitro/in vivo correlation.
    Zhao L; Li Y; Fang L; He Z; Liu X; Wang L; Xu Y; Ren C
    Int J Pharm; 2009 Jun; 374(1-2):73-81. PubMed ID: 19446762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative in vivo evaluation of propranolol hydrochloride after oral and transdermal administration in rabbits.
    Rao PR; Reddy MN; Ramakrishna S; Diwan PV
    Eur J Pharm Biopharm; 2003 Jul; 56(1):81-5. PubMed ID: 12837485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formulation development, in vitro and in vivo evaluation of membrane controlled transdermal systems of glibenclamide.
    Mutalik S; Udupa N
    J Pharm Pharm Sci; 2005 Jan; 8(1):26-38. PubMed ID: 15946595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biodegradable derivatives of tranexamic acid as transdermal permeation enhancers.
    Vávrová K; Hrabálek A; Dolezal P; Holas T; Klimentová J
    J Control Release; 2005 May; 104(1):41-9. PubMed ID: 15866333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies.
    Panchagnula R; Bokalial R; Sharma P; Khandavilli S
    Int J Pharm; 2005 Apr; 293(1-2):213-23. PubMed ID: 15778059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double-layer weekly sustained release transdermal patch containing gestodene and ethinylestradiol.
    Gao Y; Liang J; Liu J; Xiao Y
    Int J Pharm; 2009 Jul; 377(1-2):128-34. PubMed ID: 19463930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and evaluation of occlusive systems employing polyvinyl alcohol for transdermal delivery of sumatriptan succinate.
    Balaguer-Fernández C; Padula C; Femenía-Font A; Merino V; Santi P; López-Castellano A
    Drug Deliv; 2010 Feb; 17(2):83-91. PubMed ID: 20067437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of pressure sensitive adhesives and chemical permeation enhancers on the permeability of fentanyl through excised rat skin.
    Mehdizadeh A; Ghahremani MH; Rouini MR; Toliyat T
    Acta Pharm; 2006 Jun; 56(2):219-29. PubMed ID: 16613727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.